Elevated baseline LDH levels predict worse clinical outcomes in heart failure with reduced ejection fraction and modestly ...

Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...

A simple blood test measuring circulating tumor DNA (ctDNA) could help doctors predict how well treatment will work for some patients with advanced breast cancer.

—A retrospective analysis of patients with acetylcholine receptor antibody (AChR-Ab)-positive generalized myasthenia gravis (MG) who underwent thymectomy found that a majority of them had good ...